Category: Oncology/Hematology
North America Oncology/Hematology
-
Multiple Myeloma Therapeutics
... at a CAGR of 14.5% over the analysis period 2024-2030. Chemotherapy & Other Drugs, one of the segments analyzed in the report, is expected to record a 15.3% CAGR and reach US$37.6 Billion by the ... Read More
-
Prostate Cancer Diagnostics
... at a CAGR of 13.3% over the analysis period 2024-2030. Preliminary Test, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$10.0 Billion by the end of ... Read More
-
2025 North America Cancer Diagnostics Market in the USA, Canada, Mexico - 2024 Supplier Shares and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... LeadingMarketResearch.com provides information and analysis not available from any other published source , including 2024 supplier strategies and shares by country, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides ... Read More
-
2025 US Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Mexico Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Canada Cancer Diagnostics Market - 2024 Supplier Shares and Strategies, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... any other published source , including 2024 supplier strategies and shares, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a comprehensive lists of companies developing or marketing new technologies ... Read More
-
2025 Global Cancer Diagnostics Market in the USA, Europe, Japan - 2024 Supplier Shares and Strategies by Country, 2024-2029 Volume and Sales Segment Forecasts for over 40 Individual Tumor Markers
... provides information and analysis not available from any other published source , including 2024 supplier strategies and shares by country, and 2024-2029 volume and sales forecasts for major tumor markers. The report also provides a ... Read More
-
2025 United States Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment ... Read More
-
2025 North America Cancer Biomarkers Market Forecast (2025-2030 Outlook)-High Tech Outlook Report
... Medical Device Mfg. industry. The global market is expected to increase from USD xx billion in 2026 to USD xx billion by 2031, at a CAGR of xx% from 2026 to 2031. Estimates on equipment ... Read More
-
T-Cell Therapy Market by Type of Therapy (CAR-T, TCR, and TIL), Target Indications (Acute Lymphoblastic Leukemia, Non-Hodgkin’s Lymphoma, Melanoma, Bladder Cancer, Lung Cancer, Head, and Neck Cancer, Multiple Myeloma, Sarcoma, Chronic Lymphocytic Leukemia, Ovarian Cancer, Esophageal Cancer, Colorectal Cancer, Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Acute Myeloid Leukemia, and Renal Cell Carcinoma), Target Antigens (CD19, BCMA, CD19/22, EGFR, NY-ESO-1, gp100, p53, EBV, MUC1, WT-1, and Others), and Key Geographical Regions (North America, Europe and Asia Pacific, Latin America, Middle East, and North Africa): Industry Trends and Global Forecasts, Till 2035
... Esophageal Cancer, Colorectal Cancer, Nasopharyngeal Carcinoma, Hepatocellular Carcinoma, Acute Myeloid Leukemia, and Renal Cell Carcinoma), Target Antigens (CD19, BCMA, CD19/22, EGFR, NY-ESO-1, gp100, p53, EBV, MUC1, WT-1, and Others), and Key Geographical Regions (North America, ... Read More
-
Global TCR Therapy Market by Target Indication (Nasopharyngeal Carcinoma, Multiple Myeloma, Head and Neck Carcinoma, Sarcoma, Melanoma, Acute Myeloid Leukemia, Lung Cancer, Ovarian Cancer, and Merkel Cell Cancer), Target Antigen (NY-ESO-1, EBV, gp100, and others), Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, Till 2035
... Key Players and Key Geographies (North America, Europe, Asia Pacific, Latin America, Middle East and North Africa, and Rest of the World): Industry Trends and Global Forecasts, Till 2035 Global TCR Therapy Market: Overview As ... Read More
-
Brachytherapy Market Research Report Information, By Product (Afterloaders & Applicators, Radioactive Seeds, Electronic Brachytherapy, Imaging Systems, and Others), By Type (High Dose-Rate (HDR) Brachytherapy, Low Dose-Rate (LDR) Brachytherapy), By Technique (Interstitial Brachytherapy, Intracavitary Brachytherapy), By Indication (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, and Others), By End-Users (Hospitals & Specialty Clinics, Cancer Treatment Centers, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Industry Forecast Till 2032
... Indication (Prostate Cancer, Breast Cancer, Cervical Cancer, Skin Cancer, and Others), By End-Users (Hospitals & Specialty Clinics, Cancer Treatment Centers, and Others) And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) Industry ... Read More
-
2024-2029 US Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline LeadingMarketResearch’s new report is a study of the major business opportunities emerging in the U.S. immunodiagnostic market during the next five years. ... Read More
-
2024-2029 Mexico Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline This new report from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in ... Read More
-
2024-2029 Global Clinical Chemistry and Immunodiagnostic Analyzers and Reagents - 2024 Supplier Shares, 2024-2029 Volume and Sales Segment Forecasts for 100 Tests in the US, Europe and Japan - Abused Drugs, Cancer, Chemistry, Endocrine, Immunoprotein, TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline
... TDM and Other Assays - High-Growth Opportunities for Suppliers, Competitive Analysis and Growth Strategies, Latest Technologies and Instrumentation Pipeline LeadingMarketResearch.com's new report is a seven-country strategic analysis of major business opportunities emerging in the immunodiagnostic ... Read More
-
2024-2029 Hematology and Flow Cytometry: US, Europe, Japan - A Market Facing Regulatory and Competitive Challenges - Supplier Shares and Segment Forecasts by Test - Technological Breakthroughs, Emerging Tests, Competitive Analysis
... is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the global hematology and flow cytometry markets during the next five years. The report explores business and technological ... Read More
-
2024-2029 Nucleic Acid Testing (NAT) Market: US, Europe, Japan - Supplier Sales and Shares by Test, Volume and Sales Forecasts for 100 Infectious, Cancer and Genetic Diseases, Forensic and Paternity Testing/HLA Typing - Technological Breakthroughs, Emerging Tests, Competitive Analysis
... Emerging Tests, Competitive Analysis This new seven-country study from LeadingMarketResearch.com is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the molecular diagnostics market during the next ... Read More
-
Metastatic Lung Adenocarcinoma Treatment Market Size, Share, Trends, Industry Analysis Report: By Treatment (Chemotherapy, Targeted Therapy, Immunotherapy, Radiation Therapy, and Others), End User (Hospitals, Specialty Clinics, and Others), and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) – Market Forecast, 2025–2034
... Latin America, and Middle East & Africa) – Market Forecast, 2025–2034 The global metastatic lung adenocarcinoma treatment market size is expected to reach USD 14.17 billion by 2034, according to a new study by Polaris ... Read More
-
2024 United States Cancer Diagnostics Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 North America Immunotherapy Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Immunotherapy Drugs Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 United States Lung Cancer Surgery Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 United States Breast Cancer Therapeutics Forecast (2025-2030 Outlook)-Market Opportunities Report
... NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and service ... Read More
-
2024 North America Cancer Supportive Care Drugs Forecast (2025-2030 Outlook)-Market Opportunities Report
... the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product and ... Read More
-
2024 United States Pd-1 And Pd-L1 Inhibitors Market Forecast (2025-2030 Outlook)-Market Opportunities Report
... within the NAICS Healthcare industry. The market is expected to increase from USD xx billion in 2025 to USD xx billion by 2030, at a CAGR of xx% from 2025 to 2030. Estimates on product ... Read More
Research Assistance
